EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Network‐based precision medicine and systems pharmacology

Arvind K Pandey, Susan Dina Ghiassian, Joseph Loscalzo

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70184 ↗

At a glance

Übersichtsarbeit in British Journal of Pharmacology, 2026. Written by Arvind K Pandey and 2 co-authors. Institution: Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Major MEDLINE topics: Precision Medicine, Network Pharmacology. Cited 11 times so far (Crossref); 141 references. The full text is freely available in PubMed Central. Funded by: American Heart Association, NIH HHS, NHLBI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The growth in detailed multi‐omic profiling has created new opportunities to tailor clinical care and therapy to patient‐level variations in disease phenotype. However, efforts towards precision medicine and personalised therapeutics are hampered by limitations in identifying biologically relevant signals that correlate with and underlie disease activity and therapeutic response from these growing arrays of data. These complexities are accentuated further when attempting to translate the new insights in disease pathobiology into new drug targets for treatment. Additionally, understanding how best to reposition existing drugs in the context of new data on disease pathogenesis remains a challenge. Network medicine provides one approach to comprehend these large data sets and identify better the key molecular and phenotypic signals that can function as disease and treatment biomarkers and that can be targeted for therapy. In this review, we discuss basic concepts in the application of network science to biological systems and then build on these concepts to discuss network‐based approaches for identifying novel disease biomarkers, elucidating new drug targets and repositioning existing drugs for new indications. LINKED ARTICLES This article is part of a themed issue Network Medicine and Systems Pharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.8/issuetoc

Subjects

MeSH terms (MEDLINE)

Precision MedicineNetwork PharmacologyHumansAnimalsBiomarkers

Author keywords

biomarkersdrug repurposingnetwork medicinenetwork pharmacology

Substances

Biomarkers

Authors and institutions

  • Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Scipher Medicine Corporation, Waltham, Massachusetts, USA.

Funding

  • American Heart Association
  • NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health

Cite

APA

Pandey, A. K., Ghiassian, S. D., & Loscalzo, J. (2026). Network‐based precision medicine and systems pharmacology. British Journal of Pharmacology. https://doi.org/10.1111/bph.70184

Vancouver

Pandey AK, Ghiassian SD, Loscalzo J. Network‐based precision medicine and systems pharmacology. British Journal of Pharmacology. 2026. doi:10.1111/bph.70184

BibTeX
@article{Pandey2026,
  author = {Pandey, Arvind K and Ghiassian, Susan Dina and Loscalzo, Joseph},
  title = {Network‐based precision medicine and systems pharmacology},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70184}
}
Start for free →